demonstrated that a 5.6% weight loss in the group treated with liraglutide 1.8 mg/day compared with placebo was associated to reductions in both total fat and lean body mass measured by Dual-Energy X-ray Absorptiometry (DXA), as well as in visceral and subcutaneous adipose tissues measured by Magnetic Resonance Imaging (MRI) [54]
GLP-1 drugs have a theoretical association with pancreatitis risk, though causality is debated
Meal Sizing: Large meals put excessive pressure on the LES
Strength training, in particular, can increase muscle mass and support a higher resting metabolic rate
van Albada, [email protected] This article was submitted to Pediatric Endocrinology, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Do not leave it on the counter